Skip to main content
. 2014 Jul 29;111(6):1180–1187. doi: 10.1038/bjc.2014.427

Figure 1.

Figure 1

Cytoplasmic STMN1 expression in different urinary bladder cancer tumour stages. (A) Normal ( × 20) with negative expression, (B) low-grade Ta tumour ( × 20) with weak expression, (C) high-grade T1 tumour ( × 20) with moderate/strong expression and (D) high-grade T2 tumour ( × 20) with moderate/strong expression. Moderate/strong expression of STMN1 in metastatic urinary bladder cancer exemplified in E. A high-grade T3 primary tumour ( × 20) and (F) matching sentinel lymph node metastasis ( × 20).